查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1371931

全球肉毒桿菌市場，預測到 2030 年：按產品類型、性別、年齡層、用途、最終用戶和地區進行全球分析

Botox Market Forecasts to 2030 - Global Analysis By Product Type (Botulinum Toxin B, Botulinum Toxin A and Other Product Types), Gender (Male and Female), Age Group, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2023 年全球 Botox 市場規模為 72.6 億美元，預計到 2030 年將達到 176.3 億美元，預測期內年複合成長率為 13.5%。

肉毒桿菌產生的神經毒性蛋白質稱為肉毒桿菌或肉毒桿菌毒素。它在醫學和美容上都用於暫時麻痺或放鬆肌肉。它也用於治療多汗症、慢性頭痛、肌肉痙攣和運動異常等疾病。肉毒桿菌由合格的醫療專業人員給藥，謹慎給藥對於防止不良反應非常重要。

根據美國整形外科醫生協會的報告，2020 年肉毒桿菌手術減少了近 13%。

肉毒桿菌注射的需求增加

肉毒桿菌注射還有許多其他好處，主要是改善外觀。例如，肉毒桿菌注射經常用於放鬆顳顎關節(TMJ) 的肌肉和其他類型的肌肉疼痛。此外，包括偏頭痛在內的慢性健康問題可以透過注射肉毒桿菌來治療，它可以透過阻斷肌肉神經的活動來減少肌肉的過度使用。因此，肉毒桿菌注射可以幫助那些腋下出汗過多、泌尿道問題和膀胱過動症的人。

成本高

對許多人來說，Botox（肉毒桿菌）的高成本可能是一個主要障礙。費用可能會阻礙獲得治療，特別是對於那些沒有足夠經濟能力或健康保險的人來說。此外，這種經濟障礙可能會阻止人們利用毒素的藥用和美容效果，從而降低他們的生活品質並降低他們的自尊。由於Botox治療是連續的，往往需要在很長一段時間內進行多次治療，這增加了成本負擔。

非侵入性手術需求增加

40歲以上的人傾向於重視自己的外表並希望看起來更年輕。因此，特別是在已開發國家，女性對美學特徵的興趣預計將增加，對非侵入性手術的需求將加速。此外，肉毒桿菌毒素也用於治療多種與老化相關的問題，包括魚尾紋、眉間紋和額頭皺紋。因此，40歲以上的人更容易出現這些老化症狀。因此，肉毒桿菌手術在40歲至54歲之間的人群中越來越受歡迎，推動了市場的成長。

副作用

肉毒桿菌治療因其低風險和副作用而受到高度讚揚，通常在 24 至 48 小時內消失。此外，對某些人來說，副作用可能會持續數週。例如噁心、上眼瞼下垂、肩膀僵硬和頭痛。因此，經常會發生過敏反應。因此，服用抗生素的人在接受肉毒桿菌治療前應格外小心。

COVID-19 的影響

為阻止病毒傳播而採取的限制和封鎖措施導致許多皮膚科和美容診所暫時關閉，限制了肉毒桿菌治療的獲得。由於整容手術等非必要醫療程序被推遲或取消，對肉毒桿菌注射的需求有所下降。而且，由於疫情引發的經濟危機，人們面臨經濟困難，對擇期整容花錢持謹慎態度。因此，總體而言，COVID-19 的爆發對 Botox 市場產生了重大影響，導致這些手術的需求和銷售下降。

皮膚科診所預計在預測期內將是最大的

據估計，皮膚科診所所佔佔有率最大。肉毒桿菌毒素經常在皮膚科職場給藥，特別是在美容方面使用時。此外，這些診所專門診斷和治療各種皮膚病，並提供肉毒桿菌注射，這是消除臉部皺紋和細紋的首選非手術方法。皮膚科醫師有能力評估患者的需求、選擇適當的給藥並適當地進行注射。此外，皮膚科診所提供可控且衛生的氛圍，這就是為什麼尋求美容改善的顧客經常光顧的原因。

預計治療領域在預測期內將經歷最高的年複合成長率。

預計治療領域在預測期內將出現最高的年複合成長率。這是因為使用肉毒桿菌進行各種治療和預防治療，包括持續性偏頭痛、膀胱過動症和多汗症。此外，對許多肉毒桿菌毒素的作用機制和莫耳行為的了解的提高擴大了它們的治療潛力。多汗症和反覆頭痛只是可以用肉毒桿菌治療的眾多疾病中的兩種。因此，這些方面正在推動市場成長。

比最大的地區

由於可支配所得的增加、美容肉毒桿菌程序的技術進步以及最先進的手術和治療設施，北美在估計期間佔據了最大的市場佔有率。進一步促進該地區收益成長的是整容手術的需求不斷成長、各種肉毒桿菌治療的核准加快和檢驗。

複合年複合成長率最高的地區

由於增加了對推出新產品的研發項目的投資，預計歐洲在預測期內將實現盈利成長。例如，根據國際美容整形外科外科協會 (ISAPS)（2021 年）的數據，西班牙進行了 208,764 例非手術整容手術，其中包括 75,348 例肉毒桿菌治療。此外，英國肉毒桿菌毒素市場在歐洲地區成長最快，而德國肉毒桿菌素市場佔有最大的市場佔有率。

免費客製化服務

訂閱此報告的客戶有權獲得以下免費自訂選項之一：

  • 公司簡介
    • 其他市場公司的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和年複合成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章 執行摘要

第2章 前言

  • 概述
  • 利害關係人
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 研究來源
    • 主要研究來源
    • 二次研究來源
    • 先決條件

第3章 市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章 全球肉毒桿菌市場：依產品類型

  • 肉毒桿菌B
  • A型肉毒桿菌毒素
    • 運動障礙
    • 肉毒桿菌
    • 索敏
  • 其他產品類型

第6章 全球肉毒桿菌市場：依性別

  • 男性
  • 女士

第7章 全球肉毒桿菌市場：依年齡層

  • 13-19歲
  • 20-29歲
  • 30-39歲
  • 40-54歲
  • 55歲以上

第8章 全球肉毒桿菌市場：依用途

  • 療法
    • 膀胱過動症
    • 慢性偏頭痛
    • 痙攣
    • 頸部肌張力障礙
    • 其他治療方法
  • 美學
    • 眉毛之間的線
    • 魚尾紋
    • 額頭線
    • 其他美學
  • 其他用途

第9章 全球肉毒桿菌市場：依最終用戶分類

  • 水療/美容中心
  • 醫院
  • 皮膚科診所
  • 其他最終用戶

第10章 全球肉毒桿菌市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東/非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東/非洲

第11章進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第12章公司簡介

  • WorldMeds LLC.
  • Syneron Candela
  • Solta Medical.
  • AbbVie
  • Allergan Inc.
  • Eisai Co., Ltd.
  • Evolus, Inc.
  • Galderma SA
  • Hugel, Inc
  • Ipsen Group
  • Lanzhou Institute of Biological Products Co. Ltd.
  • Lumenis
  • Medy Tox Inc.
  • Merz Pharma.
  • Pfizer Inc.
  • Revance Therapeutics Inc.
  • Solta Medical.
Product Code: SMRC23988

According to Stratistics MRC, the Global Botox Market is accounted for $7.26 billion in 2023 and is expected to reach $17.63 billion by 2030 growing at a CAGR of 13.5% during the forecast period. A neurotoxic protein generated from the bacteria Clostridium botulinum is known as botox or botulinum toxin. It is used both medically and cosmetically to temporarily paralyze or relax muscles. It is also used to treat medical diseases such as hyperhidrosis, chronic headaches, muscle spasms, and movement abnormalities. Botox is administered by qualified medical personnel to prevent negative consequences, careful administration is crucial.

According to the America Society of Plastic Surgeon report, nearly 13% dip were observed in botulinum toxin procedures in 2020.

Market Dynamics:

Driver:

Rising demand in Botox injections

Botox injections have numerous other benefits, primarily enhancing physical appearance. For instance, Botox injections are frequently used to help people with temporomandibular joint (TMJ) or other types of muscle pain relax their muscles. Additionally, chronic health issues, including migraines, are treated with botox injections, it can reduce the excessive use of the muscles by blocking the activity of the muscles' nerves. Hence, botox injections can help those who experience excessive underarm sweating, urinary tract disorders, or an overactive bladder.

Restraint:

High Costs

For many people, the high expense of (botulinum toxin) Botox, might be a substantial barrier. Access to the treatment may be hampered by the cost, especially for those without sufficient financial means or health insurance. Furthermore, this financial barrier may hinder people from taking advantage of the toxin's medicinal or aesthetic effects, which may lower their quality of life or lower their self-esteem. Thus, the cost burden is made higher by the ongoing nature of botox treatments, which often call for several sessions over time.

Opportunity:

Increase in demand for non-invasive surgeries

People over the age of 40 tend to focus on their physical appearance and want to look young. Thus, it is projected that increasing female attention to aesthetic traits, particularly in developed nations, will accelerate the expansion of the demand for non-invasive surgeries. Additionally, botulinum toxin is utilized to treat a variety of aging-related problems, including crow's feet, glabellar lines, forehead lines, and others. People over 40 are therefore more likely to experience these indicators of aging. Therefore, botulinum toxin operations are becoming increasingly popular among people between the ages of 40 and 54, which are boosting market growth.

Threat:

Side Effects

Botox procedures are well regarded for having fewer risks and few side effects that typically go away within 24-48 hours. Moreover, some people could experience adverse effects that can continue for weeks. Examples of these include nausea, droopy eyes, a stiff neck, headaches, and more. Therefore, allergic reactions have often occurred; as a result, individuals taking antibiotics should take extra care before receiving botox therapy.

COVID-19 Impact

The limitations and lockdown measures put in place to stop the virus's spread led to the temporary closure of numerous dermatological and beauty clinics, which restricted access to botox treatments. Botox injection demand decreased as a result of non-essential medical procedures, such as aesthetic procedures, being delayed or stopped. Additionally, the economic crisis brought on by the epidemic has caused people to face financial difficulties, which have pushed them to be more careful about spending money on elective cosmetic surgeries. Therefore, in overall, the COVID-19 pandemic has drastically impacted the market for Botox, leading to a decline in demand and sales for these procedures.

The dermatology clinics segment is expected to be the largest during the forecast period

The dermatology clinics segment is estimated to hold the largest share. Botulinum toxin is frequently administered in dermatology workplaces, especially when used cosmetically. Additionally, these clinics specialize in the diagnosis and treatment of various skin diseases and provide botulinum toxin injections, a well-liked non-surgical method for eradicating wrinkles and small lines on the face. Dermatologists have the skills to evaluate patients' needs, choose the right dosage, and properly administer injections because they are licensed medical professionals. Furthermore, a controlled and hygienic atmosphere is offered by dermatology clinics, which frequently draw clients looking for cosmetic improvements.

The therapeutics segment is expected to have the highest CAGR during the forecast period

The therapeutics segment is anticipated to have highest CAGR during the forecast period, due to a variety of therapeutic and preventive treatments, including those for persistent migraines, overactive bladders, and hyperhidrosis, are carried out using botox procedures. Additionally, enhanced knowledge of the many mechanisms of action and molar behaviour of botulinum toxin has expanded its therapeutic potential. Hyperhidrosis and recurrent headaches are only two of the many disorders that can be treated with botox. Therefore, these aspects drive the market's growth.

Region with largest share:

North America commanded the largest market share during the extrapolated period due to the rising disposable income, technological advancements in aesthetic botox procedures, and state-of-the-art facilities for surgery and treatment. Additionally, contributing to revenue growth in the area is the rising demand for cosmetic procedures, quick approvals, and verification of various botox treatments.

Region with highest CAGR:

Europe is expected to witness profitable growth over the projection period, owing to the increased investment in R&D projects to launch new products is in the European region. For instance, according to the International Society of Aesthetic Plastic Surgery (ISAPS) (2021), 208,764 nonsurgical cosmetic procedures, including 75,348 botulinum toxin treatments, were performed in Spain. Additionally, the UK botulinum toxin market had the quickest rate of growth in the European region, while the German botulinum toxin market held the greatest market share.

Key players in the market:

Some of the key players in the Botox Market include: WorldMeds LLC., Syneron Candela, Solta Medical, AbbVie, Allergan Inc., Eisai Co., Ltd., Evolus, Inc.,Galderma S.A., Hugel, Inc, Ipsen Group, Lanzhou Institute of Biological Products Co. Ltd., Lumenis, Medy Tox Inc., Merz Pharma., Pfizer Inc., Revance Therapeutics Inc. and Solta Medical.

Key Developments:

In October 2022, Galderma and National Breast Cancer Foundation Inc. (NBCF) kept on their collaboration. Breast cancer survivors who had Restylane, Dysport (abobotulinumtoxinA), and/or Sculptra during Breast Cancer Awareness Month were profiled in a promotion on Galderma's social media channels.

In August 2022, the collaboration between Medytox and Bloomage Biotechnology has ended. According to Bloomage Biotechnology, since the joint venture agreement was signed, Medytox has never offered goods made by Medybloom China BTX for sale.

In July 2022, Fastox Pharma debuted the long-lasting botulinum toxin, known as LAST technology, during the "Toxins 2022 International Conference." Fastox discovered that the commencement of action of botulinum toxin type A (BoNT/A) should be accelerated by the addition of fast-acting myorelaxant drugs.

Product Types Covered:

  • Botulinum Toxin B
  • Botulinum Toxin A
  • Other Product Types

Genders Covered:

  • Male
  • Female

Age Groups Covered:

  • 13-19
  • 20-29
  • 30-39
  • 40-54
  • 55 and above

Applications Covered:

  • Therapeutics
  • Aesthetics
  • Other Applications

End Users Covered:

  • Spas and Cosmetic Centers
  • Hospitals
  • Dermatology Clinics
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Botox Market, By Product Type

  • 5.1 Introduction
  • 5.2 Botulinum Toxin B
  • 5.3 Botulinum Toxin A
    • 5.3.1 Dysport
    • 5.3.2 Botox
    • 5.3.3 Xeomin
  • 5.4 Other Product Types

6 Global Botox Market, By Gender

  • 6.1 Introduction
  • 6.2 Male
  • 6.3 Female

7 Global Botox Market, By Age Group

  • 7.1 Introduction
  • 7.2 13-19
  • 7.3 20-29
  • 7.4 30-39
  • 7.5 40-54
  • 7.6 55 and above

8 Global Botox Market, By Application

  • 8.1 Introduction
  • 8.2 Therapeutics
    • 8.2.1 Overactive Bladder
    • 8.2.2 Chronic Migraine
    • 8.2.3 Spasticity
    • 8.2.4 Cervical Dystonia
    • 8.2.5 Other Therapeutics
  • 8.3 Aesthetics
    • 8.3.1 Glabellar Lines
    • 8.3.2 Crow's Feet
    • 8.3.3 Forehead Lines
    • 8.3.4 Other Aesthetics
  • 8.4 Other Applications

9 Global Botox Market, By End User

  • 9.1 Introduction
  • 9.2 Spas and Cosmetic Centers
  • 9.3 Hospitals
  • 9.4 Dermatology Clinics
  • 9.5 Other End Users

10 Global Botox Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 WorldMeds LLC.
  • 12.2 Syneron Candela
  • 12.3 Solta Medical.
  • 12.4 AbbVie
  • 12.5 Allergan Inc.
  • 12.6 Eisai Co., Ltd.
  • 12.7 Evolus, Inc.
  • 12.8 Galderma S.A.
  • 12.9 Hugel, Inc
  • 12.10 Ipsen Group
  • 12.11 Lanzhou Institute of Biological Products Co. Ltd.
  • 12.12 Lumenis
  • 12.13 Medy Tox Inc.
  • 12.14 Merz Pharma.
  • 12.15 Pfizer Inc.
  • 12.16 Revance Therapeutics Inc.
  • 12.17 Solta Medical.

List of Tables

  • Table 1 Global Botox Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Botox Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 3 Global Botox Market Outlook, By Botulinum Toxin B (2021-2030) ($MN)
  • Table 4 Global Botox Market Outlook, By Botulinum Toxin A (2021-2030) ($MN)
  • Table 5 Global Botox Market Outlook, By Dysport (2021-2030) ($MN)
  • Table 6 Global Botox Market Outlook, By Botox (2021-2030) ($MN)
  • Table 7 Global Botox Market Outlook, By Xeomin (2021-2030) ($MN)
  • Table 8 Global Botox Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 9 Global Botox Market Outlook, By Gender (2021-2030) ($MN)
  • Table 10 Global Botox Market Outlook, By Male (2021-2030) ($MN)
  • Table 11 Global Botox Market Outlook, By Female (2021-2030) ($MN)
  • Table 12 Global Botox Market Outlook, By Age Group (2021-2030) ($MN)
  • Table 13 Global Botox Market Outlook, By 13-19 (2021-2030) ($MN)
  • Table 14 Global Botox Market Outlook, By 20-29 (2021-2030) ($MN)
  • Table 15 Global Botox Market Outlook, By 30-39 (2021-2030) ($MN)
  • Table 16 Global Botox Market Outlook, By 40-54 (2021-2030) ($MN)
  • Table 17 Global Botox Market Outlook, By 55 and above (2021-2030) ($MN)
  • Table 18 Global Botox Market Outlook, By Application (2021-2030) ($MN)
  • Table 19 Global Botox Market Outlook, By Therapeutics (2021-2030) ($MN)
  • Table 20 Global Botox Market Outlook, By Overactive Bladder (2021-2030) ($MN)
  • Table 21 Global Botox Market Outlook, By Chronic Migraine (2021-2030) ($MN)
  • Table 22 Global Botox Market Outlook, By Spasticity (2021-2030) ($MN)
  • Table 23 Global Botox Market Outlook, By Cervical Dystonia (2021-2030) ($MN)
  • Table 24 Global Botox Market Outlook, By Other Therapeutics (2021-2030) ($MN)
  • Table 25 Global Botox Market Outlook, By Aesthetics (2021-2030) ($MN)
  • Table 26 Global Botox Market Outlook, By Glabellar Lines (2021-2030) ($MN)
  • Table 27 Global Botox Market Outlook, By Crow's Feet (2021-2030) ($MN)
  • Table 28 Global Botox Market Outlook, By Forehead Lines (2021-2030) ($MN)
  • Table 29 Global Botox Market Outlook, By Other Aesthetics (2021-2030) ($MN)
  • Table 30 Global Botox Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 31 Global Botox Market Outlook, By End User (2021-2030) ($MN)
  • Table 32 Global Botox Market Outlook, By Spas and Cosmetic Centers (2021-2030) ($MN)
  • Table 33 Global Botox Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 34 Global Botox Market Outlook, By Dermatology Clinics (2021-2030) ($MN)
  • Table 35 Global Botox Market Outlook, By Other End Users (2021-2030) ($MN)

Table Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.